Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 1
This trial looked at helping the immune system recognise and attack lung cancer cells. It was for people who had lung cancer that had grown into nearby tissue or had spread to another part of the body.
The trial was supported by Cancer Research UK. It was open for people to join between 2018 and 2022. The team analysed the results in 2023.
Recruitment start: 11 May 2018
Recruitment end: 22 February 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Christian Ottensmeier
Professor Gary Middleton
Cancer Research UK - regulatory@cancer.org.uk (trial sponsor )
The CRUK trial number is CRUKD/17/003.
There is more information about this trial on the clinicaltrials.gov website (NCT03371485):
https://clinicaltrials.gov/ct2/show/NCT03371485(link is external)
Last reviewed: 28 June 2023
CRUK internal database number: 15137
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
